Hepatic Artery Chemoembolization for Hepatocellular Carcinoma Recurrence Confined to the Transplanted Liver
Background: Careful hepatocellular carcinoma (HCC) case selection permits orthotopic liver transplantation with the expectation of around 70% plus 5-year survival. However, many patients have tumor recurrences and there is little literature guidance in the management of these patients. Aims: A retro...
Main Author: | Brian I. Carr |
---|---|
Format: | Article |
Language: | English |
Published: |
Karger Publishers
2012-09-01
|
Series: | Case Reports in Oncology |
Subjects: | |
Online Access: | http://www.karger.com/Article/FullText/343043 |
Similar Items
-
Prospective Phase II trial of drug-eluting bead chemoembolization for liver transplant candidates with hepatocellular carcinoma and marginal hepatic reserve
by: Fidelman N, et al.
Published: (2019-06-01) -
Transcatheter arterial chemoembolization of hepatocellular carcinoma on liver cirrhosis in patients awaiting liver transplantation
by: A. S. Polekhin, et al.
Published: (2021-04-01) -
Radiological appearance of hepatocellular carcinoma predicts the response to trans-arterial chemoembolization in patients undergoing liver transplantation
by: Wei Zhang, et al.
Published: (2019-11-01) -
Successful Treatment of Hepatocellular Carcinoma with Transcatheter Arterial Chemoembolization followed by Radical Liver Transplantation in a Patient with Severe Liver Damage
by: Hajime Nakamura, et al.
Published: (2019-04-01) -
FEATURES ARTERIAL ANATOMY OF THE LIVER AND ENDOVASCULAR CHEMOEMBOLIZATION OF THE HEPATIC ARTERY IN THE TREATMENT OF PRIMARY AND METASTATIC LIVER CANCERS
by: V. V. Plechev, et al.
Published: (2017-02-01)